BMC Infectious Diseases (Apr 2022)

Aureobasidium melanigenum catheter-related bloodstream infection: a case report

  • Shinya Yamamoto,
  • Mahoko Ikeda,
  • Yuki Ohama,
  • Tomohiro Sunouchi,
  • Yasutaka Hoshino,
  • Hiroshi Ito,
  • Marie Yamashita,
  • Yoshiaki Kanno,
  • Koh Okamoto,
  • Satoshi Yamagoe,
  • Yoshitsugu Miyazaki,
  • Shu Okugawa,
  • Jun Fujishiro,
  • Kyoji Moriya

DOI
https://doi.org/10.1186/s12879-022-07310-9
Journal volume & issue
Vol. 22, no. 1
pp. 1 – 5

Abstract

Read online

Abstract Background Aureobasidium melanigenum is a ubiquitous dematiaceous fungus that rarely causes invasive human infections. Here, we present a case of Aureobasidium melanigenum bloodstream infection in a 20-year-old man with long-term catheter use. Case presentation A 20-year-old man receiving home care with severe disabilities due to cerebral palsy and short bowel syndrome, resulting in long-term central venous catheter use, was referred to our hospital with a fever. After the detection of yeast-like cells in blood cultures on day 3, antifungal therapy was initiated. Two identification tests performed at a clinical microbiological laboratory showed different identification results: Aureobasidium pullulans from matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, and Cryptococcus albidus from a VITEK2 system. Therefore, we changed the antifungal drug to liposomal amphotericin B. The fungus was identified as A. melanigenum by DNA sequence-based analysis. The patient recovered with antifungal therapy and long-term catheter removal. Conclusion It is difficult to correctly identify A. melanigenum by routine microbiological testing. Clinicians must pay attention to the process of identification of yeast-like cells and retain A. melanigenum in cases of refractory fungal infection.

Keywords